Huangyang Meng

752 total citations
22 papers, 423 citations indexed

About

Huangyang Meng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huangyang Meng has authored 22 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huangyang Meng's work include Ferroptosis and cancer prognosis (7 papers), Cancer-related molecular mechanisms research (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Huangyang Meng is often cited by papers focused on Ferroptosis and cancer prognosis (7 papers), Cancer-related molecular mechanisms research (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Huangyang Meng collaborates with scholars based in China. Huangyang Meng's co-authors include Jinhui Liu, Sipei Nie, Rui Sun, Yicong Wan, Siyue Li, Wenjun Cheng, Jing Yang, Wenjun Cheng, Lin Zhang and Yi Jiang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cell Death and Differentiation and Life Sciences.

In The Last Decade

Huangyang Meng

20 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huangyang Meng China 12 306 236 129 85 39 22 423
Tabari M. Baker United States 6 234 0.8× 98 0.4× 71 0.6× 265 3.1× 33 0.8× 12 406
Jinxiao Liang China 10 218 0.7× 100 0.4× 26 0.2× 83 1.0× 39 1.0× 27 330
Qiyu Zhong China 8 106 0.3× 67 0.3× 74 0.6× 72 0.8× 80 2.1× 18 244
Jodi A. McKenzie United States 8 155 0.5× 54 0.2× 73 0.6× 121 1.4× 81 2.1× 30 302
Floriana Camarda Italy 7 89 0.3× 44 0.2× 46 0.4× 136 1.6× 18 0.5× 27 236
Jayne Maidens Australia 5 217 0.7× 214 0.9× 27 0.2× 97 1.1× 23 0.6× 5 387
Daniel C. Bruhm United States 8 113 0.4× 163 0.7× 70 0.5× 71 0.8× 11 0.3× 11 243
Alison Freimund Australia 8 139 0.5× 50 0.2× 37 0.3× 276 3.2× 57 1.5× 11 375
Elisabeth Breit Germany 7 86 0.3× 174 0.7× 64 0.5× 210 2.5× 12 0.3× 8 315

Countries citing papers authored by Huangyang Meng

Since Specialization
Citations

This map shows the geographic impact of Huangyang Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huangyang Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huangyang Meng more than expected).

Fields of papers citing papers by Huangyang Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huangyang Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huangyang Meng. The network helps show where Huangyang Meng may publish in the future.

Co-authorship network of co-authors of Huangyang Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Huangyang Meng. A scholar is included among the top collaborators of Huangyang Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huangyang Meng. Huangyang Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Tian, Shulin Zhou, Huangyang Meng, et al.. (2025). Overcoming Ferroptosis-Induced Exhaustion of NK Cells through Inhibition of the ATF3-Mediated Integrated Stress Response in Ovarian Cancer. International Journal of Biological Sciences. 21(12). 5531–5546.
2.
Zhang, Lin, et al.. (2024). Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperatively. Journal of Cancer Research and Clinical Oncology. 150(1). 19–19. 1 indexed citations
3.
Meng, Huangyang, et al.. (2024). YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification. Cancer Letters. 597. 217064–217064. 30 indexed citations
4.
Meng, Huangyang, et al.. (2024). FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell Death and Differentiation. 31(4). 497–510. 10 indexed citations
5.
Zhou, Lin, et al.. (2024). Beyond monotherapy: An era ushering in combinations of PARP inhibitors with immune checkpoint inhibitors for solid tumors. Biomedicine & Pharmacotherapy. 175. 116733–116733. 3 indexed citations
6.
Zhou, Xuan, Lin Yuan, Tian Chen, et al.. (2024). Olaparib combined with CDK12-IN-3 to promote genomic instability and cell death in ovarian cancer. International Journal of Biological Sciences. 20(11). 4513–4531. 2 indexed citations
7.
Zhang, Lin, Huangyang Meng, Yi Zhong, et al.. (2023). Visceral obesity determined by CT as a predictor of short-term postoperative complications in patients with ovarian cancer. Archives of Gynecology and Obstetrics. 309(4). 1491–1498.
8.
Wan, Yicong, et al.. (2022). Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovarian borderline tumor organoids. Biochemical and Biophysical Research Communications. 638. 76–83. 6 indexed citations
9.
Nie, Sipei, Lin Zhang, Jinhui Liu, et al.. (2021). ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 284–284. 107 indexed citations
10.
Nie, Sipei, Yicong Wan, Hui Wang, et al.. (2021). CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer. Journal of Ovarian Research. 14(1). 115–115. 10 indexed citations
11.
Liu, Jinhui, Jing Yang, Feng Gao, et al.. (2020). A microRNA–Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer. DNA and Cell Biology. 39(7). 1328–1346. 11 indexed citations
12.
Liu, Jinhui, Sipei Nie, Siyue Li, et al.. (2020). Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma. Annals of Translational Medicine. 8(14). 868–868. 20 indexed citations
13.
Liu, Jinhui, Sipei Nie, Zhipeng Wu, et al.. (2020). Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment. Genomics. 112(5). 3117–3134. 31 indexed citations
14.
Meng, Huangyang, Jinhui Liu, Jiangnan Qiu, et al.. (2020). Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma. DNA and Cell Biology. 39(5). 848–863. 17 indexed citations
15.
Liu, Jinhui, Huangyang Meng, Sipei Nie, et al.. (2020). Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment exploration. Genomics. 112(6). 4827–4841. 53 indexed citations
16.
Liu, Jinhui, Siyue Li, Feng Gao, et al.. (2020). Nine glycolysis-related gene signature predicting the survival of patients with endometrial adenocarcinoma. Cancer Cell International. 20(1). 183–183. 31 indexed citations
17.
Liu, Jinhui, Zhipeng Wu, Rui Sun, et al.. (2020). Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA. Life Sciences. 258. 118231–118231. 22 indexed citations
18.
Liu, Jinhui, Sipei Nie, Zhipeng Wu, et al.. (2020). Exploration of a Novel Prognostic Risk Signatures and Immune Checkpoint Molecules in Endometrial Carcinoma Microenvironment. SSRN Electronic Journal. 2 indexed citations
19.
Liu, Jinhui, Huangyang Meng, Siyue Li, et al.. (2019). Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis. Frontiers in Genetics. 10. 1031–1031. 31 indexed citations
20.
Meng, Huangyang, Siyue Li, Sipei Nie, et al.. (2019). <p>Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6</p>. OncoTargets and Therapy. Volume 12. 10011–10022. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tabari M. Baker Breakdown of academic impact, for papers by Jinxiao Liang Breakdown of academic impact, for papers by Qiyu Zhong Breakdown of academic impact, for papers by Jodi A. McKenzie Breakdown of academic impact, for papers by Floriana Camarda Breakdown of academic impact, for papers by Jayne Maidens Breakdown of academic impact, for papers by Daniel C. Bruhm Breakdown of academic impact, for papers by Alison Freimund Breakdown of academic impact, for papers by Elisabeth Breit
Rankless by CCL
2026